These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 3910405

  • 21. [Immunologic studies using the leukocyte adherence inhibition test in the diagnosis and postoperative follow-up of breast cancer].
    Storch H, Granetzny A.
    Z Gesamte Inn Med; 1987 Jan 15; 42(2):41-4. PubMed ID: 3554795
    [Abstract] [Full Text] [Related]

  • 22. Early detection of breast cancer by leukocyte adherence inhibition assay.
    Sanner T, Kotlar HK, Eker P, Brennhovd I, Host H, Jorgensen O.
    Cancer Detect Prev; 1983 Jan 15; 6(4-5):443-50. PubMed ID: 6360351
    [Abstract] [Full Text] [Related]

  • 23. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
    Raina S, Russo AJ, Jenkins D, Goldrosen MH.
    Cancer Res; 1981 Oct 15; 41(10):3950-5. PubMed ID: 6456811
    [Abstract] [Full Text] [Related]

  • 24. [Modulating action of interferon preparations on cellular reactions of antitumor immunity].
    Mkrtchian LN, Ter-Pogosian ZR, Sarkisian OM, Gevorkian RA, Movsesian EA.
    Vopr Onkol; 1983 Oct 15; 29(8):7-11. PubMed ID: 6351429
    [Abstract] [Full Text] [Related]

  • 25. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer.
    De Carli HO, Restbergs V.
    Rev Esp Oncol; 1983 Oct 15; 30(1):25-39. PubMed ID: 6387830
    [Abstract] [Full Text] [Related]

  • 26. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
    Grosser N, Thomson DM.
    Cancer Res; 1975 Sep 15; 35(9):2571-9. PubMed ID: 1097110
    [Abstract] [Full Text] [Related]

  • 27. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y.
    Hinyokika Kiyo; 1984 Oct 15; 30(10):1367-77. PubMed ID: 6395679
    [Abstract] [Full Text] [Related]

  • 28. Immunological response of patients with tumors of the urogenital tract: a follow-up of cell-mediated antitumor immunity by the LAI test.
    Holán V, Heyberger K, Bubeník J, Hasek M, Kanka J, Laurová L.
    Neoplasma; 1977 Oct 15; 24(1):71-9. PubMed ID: 320490
    [Abstract] [Full Text] [Related]

  • 29. Peripheral blood leukocyte adherence inhibition (LAI) reactivity before and during progressive growth of B77 tumor in rats.
    Kalafut F, Klobusická M, Novotná L.
    Neoplasma; 1984 Oct 15; 31(5):507-13. PubMed ID: 6390225
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Human antitumor immunity according to leukocyte adherence inhibition test data].
    Riatsep VI, Kurtenkov OA, Nikitin IuG, Miliukhina LM.
    Vopr Onkol; 1980 Oct 15; 26(8):3-8. PubMed ID: 6998116
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of the LAI test in patients with benign and malignant breast diseases.
    Kovarík J, Lauerová L, Ninger E, Munzarová M, Feit J, Zemanová D, Wotke R.
    Neoplasma; 1983 Oct 15; 30(2):163-7. PubMed ID: 6843721
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C, Kayser S, Stumm S, Watermann I, Walter S, Stevanoviç S, Wallwiener D, Gückel B.
    Clin Cancer Res; 2003 Oct 01; 9(12):4376-86. PubMed ID: 14555509
    [Abstract] [Full Text] [Related]

  • 34. [The leukocyte adherence inhibition test in diagnostics of malignancies (author's transl)].
    Sarosiek J, Borejszo I.
    Przegl Lek; 1981 Oct 01; 38(7):561-5. PubMed ID: 7025111
    [No Abstract] [Full Text] [Related]

  • 35. Cellular and humoral factors involved in the mechanism of the micro-leukocyte adherence inhibition reaction.
    Goldrosen MH, Russo AJ, Howell JH, Leveson SH, Holyoke ED.
    Cancer Res; 1979 Feb 01; 39(2 Pt 2):587-92. PubMed ID: 367585
    [Abstract] [Full Text] [Related]

  • 36. The comparison of methods for determination of humoral and cell-mediated immunity in patients with breast cancer.
    Nedbalová M, Trojan S, Dohnalová A, Jandová A.
    Electromagn Biol Med; 2009 Feb 01; 28(3):233-9. PubMed ID: 20001700
    [Abstract] [Full Text] [Related]

  • 37. [Immunodiagnostic aspects of breast cancer. The phenomenon of leukocyte adherence inhibition].
    Fritze D, Fritze J, Kaufmann M, Drings P.
    Minerva Med; 1978 Nov 30; 69(58):3963-7. PubMed ID: 740287
    [Abstract] [Full Text] [Related]

  • 38. [Experiences with the macrophage adherence inhibition test within the framework of preparing tumor-associated antigens from human breast cancers].
    Bendix U, Bendix U.
    Allerg Immunol (Leipz); 1985 Nov 30; 31(4):273-82. PubMed ID: 2936220
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
    Ichiki AT, Quirin YP, Collmann IR, Sonoda T, Krauss S.
    J Natl Cancer Inst; 1980 Mar 30; 64(3):419-23. PubMed ID: 6986496
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.